(Q37577898)

21 August 2017

1 reference

title

Pharmacoeconomics of immunoglobulins in primary immunodeficiency (English)

1 reference

21 August 2017

Steven Simoens

1

1 reference

21 August 2017

publication date

1 August 2009

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

21 August 2017

published in

1 reference

21 August 2017

volume

9

1 reference

21 August 2017

issue

4

1 reference

21 August 2017

page(s)

375-386

1 reference

Economic assessment of different modalities of immunoglobulin replacement therapy

21 August 2017

cites work

1 reference

Immunoglobulin replacement therapy in primary antibody deficiency diseases--maximizing success

21 January 2018

1 reference

Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route

21 January 2018

1 reference

Intravenous immunoglobulin: striving for appropriate use.

21 January 2018

1 reference

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

21 January 2018

1 reference

Cost savings from intravenous immunoglobulin manufactured from chromotography/caprylate (IGIV-C) in persons with primary humoral immunodeficiency disorder

21 January 2018

1 reference

Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs

21 January 2018

1 reference

Quality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulin.

21 January 2018

1 reference

Purification of intravenous immunoglobulin G from human plasma--aspects of yield and virus safety

21 January 2018

1 reference

Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: a report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group

21 January 2018

1 reference

Changes in intravenous immunoglobulin prescribing patterns during a period of severe product shortages, 1995-2000.

21 January 2018

1 reference

Responding to the immunoglobulin shortage: a case study

21 January 2018

1 reference

Intravenous immunoglobulin: regulatory perspectives on use and supply

21 January 2018

1 reference

Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature

21 January 2018

1 reference

Shortage of human intravenous immunoglobulin—reasons and possible solutions

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERP.09.37

1 reference

21 August 2017

1 reference